BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5079121)

  • 41. Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis.
    Tejani A; Alexander S; Ettenger R; Lerner G; Zimmerman J; Kohaut E; Briscoe DM
    Pediatr Transplant; 2004 Apr; 8(2):151-60. PubMed ID: 15049795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of intravenous furosemide on blood volume].
    Berker F; Bostanci N; Kuyumcuyan K; Alhan MA; Oner M
    Tip Fak Mecm; 1966; 29(3):461-71. PubMed ID: 5966838
    [No Abstract]   [Full Text] [Related]  

  • 43. Renal lymph flow and composition during acetazolamide and furosemide diuresis.
    Bell RD
    Lymphology; 1984 Mar; 17(1):10-4. PubMed ID: 6717073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The kidney and diuretics].
    Mampel E; Koall W; Luci V
    Z Gesamte Inn Med; 1980 Sep; 35(17):Suppl 66-9. PubMed ID: 7467586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of high doses of furosemide in a case of postoperative anuria].
    Leleu JC; Laget-Corsin L
    Anesth Analg (Paris); 1972; 29(4):569-74. PubMed ID: 4647680
    [No Abstract]   [Full Text] [Related]  

  • 46. High dose frousemide in chronic renal failure.
    Fairley KF; Laver M
    Postgrad Med J; 1971 Apr; 47():Suppl:40-1. PubMed ID: 5579769
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of a new oral diuretic agent. Furosemide (Lasix).
    JAMA; 1967 Jun; 200(11):979-80. PubMed ID: 6071642
    [No Abstract]   [Full Text] [Related]  

  • 48. [Influence of modeling sodium on the dialysis disequilibrium syndrome in hemodialysis].
    Liu H; Zhu JL; Chen X
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):76-8. PubMed ID: 12934408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The use of the association of mannitol and furosemide in intracranial surgery].
    Fossa S; Battistini N; Marino C; Pallecchi AE
    Acta Anaesthesiol; 1968; 19(6):1159-70. PubMed ID: 5756941
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.
    Traeger A; Stein G; Sperschneider H; Keil E
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diuretic response to the intravenous administration of frusemide.
    McIver M; Jeremy D
    Australas Ann Med; 1967 Nov; 16(4):312-9. PubMed ID: 6080447
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of furosemide-induced increased diuresis on the pharmacodynamics of ampicillin].
    Brass H; Walther OE; Amort H
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2089-90. PubMed ID: 4216816
    [No Abstract]   [Full Text] [Related]  

  • 53. [Furosemide in renal insufficiency. Physiopathological and pharmacodynamic data].
    Guédon J; Chapman A
    Nouv Presse Med; 1974 Jun; 3(23):1499-1505. PubMed ID: 4602959
    [No Abstract]   [Full Text] [Related]  

  • 54. [Levels of plasma proteins in patients with ene stage renal failure treated with peritoneal dialysis with an addition of furosemide to dialysis fluid].
    Grzegorzewska A; Krzymański M; Antoniewicz K
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):137-40. PubMed ID: 8090666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency dependency of causal factors for hypertension in hemodialysis patients.
    Wada T; Akaike H; Sudoh S; Kato E
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1237-43. PubMed ID: 3820835
    [No Abstract]   [Full Text] [Related]  

  • 56. [Body weight telemetry in patients with endstage renal failure on hemodialysis: preliminary data].
    Schulz EG; Wagner F; Fischer N; Wolf A; Korth U; Weber MH
    Dtsch Med Wochenschr; 2007 Mar; 132(9):423-6. PubMed ID: 17315118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Optimal dosage of furosemide in patients treated with repeated dialysis].
    Jacobs C; Singlas E; Lockmane H; Tillement JP; Simon P; Legrain M
    J Urol Nephrol (Paris); 1975 Sep; 81(9):697-702. PubMed ID: 1214314
    [No Abstract]   [Full Text] [Related]  

  • 59. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
    Farghali H; Al Zuhair H; Al Windawi S; Al Hamdi A; Fariduddin M
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of massive intravenous doses of furosemide in chronic kidney failure].
    Radó J; Juhos E; Szende L; Marosi J; Takó J; Salamon F
    Orv Hetil; 1973 May; 114(21):1224-8. PubMed ID: 4705307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.